Back to search

Norway· NO-ID_9F192288-C394-480F-88C4-DA49BF4C11F6

Cyclobenzaprine HCl solco

A cyclobenzaprine product containing cyklobenzaprin, registered in Norway by Solco. The same ATC class is registered in 3 of our 19 countries.

ATC M03BX08

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedCyclobenzaprine HCl solcoATCM03BX08REGISTER NO.NO-ID_9F192288-C394-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Cyclobenzaprine is registered in 3 of 19 countries.

Countries holding a registration under ATC M03BX08 (cyclobenzaprine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 2 of them publish a price we can compare per daily dose

Cyclobenzaprine · ATC M03BX08

3 / 19 countries

  • Canada
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Cyklobenzaprin
Manufacturer
Solco
Country
Norway (NO)
ATC code
M03BX08
ATC class
Cyclobenzaprine
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • gtin
    343547400101
  • no_merkevare_id
    ID_9F192288-C394-480F-88C4-DA49BF4C11F6
  • no_varenummer
    242797
    100

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

319 interactions on record for cyclobenzaprine.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cyclobenzaprine · interactions on record

319 records

  • 20 severe
  • 113 moderate
  • 1 minor
  • 185 info

Most severe, free to view

  • FenfluramineA08AA02severe
  • DexfenfluramineA08AA04severe
  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyclobenzaprine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyclobenzaprine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Spain · Yurelax
  • Italy · Flexiban
  • Portugal · Flexiban, Miodia

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3f9c44cd-c9e5-485f-8b5a-05dec053d19a
GET /v1/drugs/3f9c44cd-c9e5-485f-8b5a-05dec053d19a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Cyklobenzaprin",
  "merkevare_id": "ID_9F192288-C394-480F-88C4-DA49BF4C11F6",
  "name_form_strength": "Cyclobenzaprine HCl solco tab 10 mg",
  "prescription_group": "C"
}

See everything about cyclobenzaprine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.